Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AGN [NYSE]
Allergan Inc.
IndexS&P 500 P/E30.36 EPS (ttm)4.21 Insider Own0.10% Shs Outstand299.11M Perf Week8.39%
Market Cap38.23B Forward P/E20.58 EPS next Y6.21 Insider Trans-5.38% Shs Float298.57M Perf Month-1.62%
Income1.27B PEG2.45 EPS next Q1.13 Inst Own89.90% Short Float1.05% Perf Quarter5.47%
Sales6.30B P/S6.07 EPS this Y17.60% Inst Trans0.01% Short Ratio1.11 Perf Half Y41.76%
Book/sh21.75 P/B5.88 EPS next Y13.59% ROA8.80% Target Price132.37 Perf Year13.20%
Cash/sh12.20 P/C10.48 EPS next 5Y12.41% ROE14.70% 52W Range81.21 - 132.04 Perf YTD15.09%
Dividend0.20 P/FCF26.33 EPS past 5Y17.90% ROI15.70% 52W High-3.21% Beta0.77
Dividend %0.16% Quick Ratio4.00 Sales past 5Y7.40% Gross Margin87.40% 52W Low57.37% ATR3.35
Employees11400 Current Ratio4.30 Sales Q/Q14.40% Oper. Margin30.50% RSI (14)56.96 Volatility3.60% 2.67%
OptionableYes Debt/Eq0.33 EPS Q/Q-1.00% Profit Margin13.80% Rel Volume2.07 Prev Close123.97
ShortableYes LT Debt/Eq0.32 EarningsMay 07 BMO Payout6.00% Avg Volume2.82M Price127.80
Recom2.00 SMA203.29% SMA502.78% SMA20024.21% Volume5,856,258 Change3.09%
07-Mar-14Reiterated Barclays Equal Weight $95 → $130
07-Feb-14Reiterated Argus Buy $110 → $130
08-Jan-14Reiterated Argus Buy $110 → $125
07-Jan-14Initiated RBC Capital Mkts Outperform $131
20-Dec-13Reiterated UBS Buy $100 → $116
20-Dec-13Reiterated BMO Capital Markets Outperform $112 → $117
31-Oct-13Reiterated Argus Buy $118 → $110
25-Jun-13Reiterated Canaccord Genuity Hold $111 → $98
24-Jun-13Downgrade Deutsche Bank Buy → Hold
02-May-13Reiterated RBC Capital Mkts Outperform $123 → $119
06-Feb-13Reiterated Stifel Nicolaus Buy $110 → $118
06-Feb-13Reiterated Canaccord Genuity Hold $102 → $111
22-Jan-13Reiterated Canaccord Genuity Hold $101 → $102
19-Sep-12Initiated Canaccord Genuity Hold $101
30-Mar-12Reiterated RBC Capital Mkts Outperform $93 → $106
29-Mar-12Reiterated UBS Buy $100 → $107
29-Mar-12Reiterated Stifel Nicolaus Buy $90 → $110
01-Dec-11Upgrade Argus Hold → Buy $95
05-Oct-11Initiated JMP Securities Mkt Perform
16-Sep-11Initiated Deutsche Bank Buy $97
15-Apr-14 01:19PM  Another Earnings Beat from J&J, View Up Zacks
14-Apr-14 11:17AM  Novartis to Shire Said to Weigh Bids for ThromboGenics at Bloomberg
11-Apr-14 08:06PM  Why Rambus, Allergan, and JAKKS Pacific Rose Today at Motley Fool
06:17PM  J&J says halting development of Botox rival Reuters
03:09PM  [$$] J&J Ending Plans for Botox Rival at The Wall Street Journal
09-Apr-14 09:25AM  Stock Upgrades: E-Trade, LinkedIn, and FireEye at Minyanville
08-Apr-14 02:43PM  Tuesday Sector Laggards: Healthcare, Financial at Forbes
07-Apr-14 04:58AM  Sector Rankings Take A Bearish Turn As The Flight To Safety Solidifies at Seeking Alpha
04-Apr-14 05:30PM  Allergan Announces Quarterly Conference Call Business Wire
28-Mar-14 06:03AM  Allergan price target raised to $140 from $130 at Citigroup theflyonthewall.com
24-Mar-14 12:25PM  May 17th Options Now Available For Allergan (AGN) at TheStreet
19-Mar-14 07:52PM  Hagens Berman: Pharmaceutical Company SkinMedica Selling Misbranded Drug Products as Cosmeceuticals Business Wire
18-Mar-14 07:17PM  The Lesson of Allergan at TheStreet
10:44AM  Auxilium rises after analyst calls 'ideal' takeover target at theflyonthewall.com
07:07AM  [$$] Veteran Investor's Top Biotech and Drug Stocks at Barrons.com
13-Mar-14 09:01AM  ALLERGAN INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
11-Mar-14 03:40PM  Kythera Regains ATX-101 from Bayer Zacks
05-Mar-14 08:37AM  Russia actions could disrupt specialty pharmaceutical sales, says Susquehanna at theflyonthewall.com
08:37AM  Russia actions could disrupt specialty pharmaceutical sales, says Susquehanna
04-Mar-14 06:31PM  Can Allergan's Growth Continue? at Motley Fool
06:31PM  Can Allergan's Growth Continue?
01:04PM  ALLERGAN INC Financials EDGAR Online Financials
08:50AM  Merrill Lynchs Top Health Care Stocks to Buy Now at 24/7 Wall St.
08:50AM  Merrill Lynchs Top Health Care Stocks to Buy Now
28-Feb-14 08:35AM  Oscar fever: Which studio stocks are golden and which are duds? Breakout
08:35AM  Oscar fever: Which studio stocks are blockbusters and which are flops? Breakout
27-Feb-14 01:17PM  [video] Future of American politics Optionetics
01:17PM  [video] Future of American politics at CNBC
01:17PM  [video] Future of American politics
12:36PM  [video] Retirement trends & US budget Optionetics
12:36PM  [video] Retirement trends & US budget at CNBC
12:36PM  [video] Retirement trends & US budget
26-Feb-14 10:03AM  Insider Trading Alert - AGN, CODE And CMI Traded By Insiders at TheStreet
25-Feb-14 02:43PM  ALLERGAN INC Files SEC form 10-K, Annual Report EDGAR Online
10:02AM  Insider Trading Alert - IDXX, AGN And BGC Traded By Insiders at TheStreet
24-Feb-14 12:08PM  October 18th Options Now Available For Allergan (AGN) at TheStreet
12:08PM  October 18th Options Now Available For Allergan (AGN)
11:03AM  Allergan: 8 Different Insiders Have Sold Shares This Month at Seeking Alpha
11:03AM  Allergan: 8 Different Insiders Have Sold Shares This Month
23-Feb-14 05:01PM  Why Is Allergan Beating the S&P 500? at Motley Fool
21-Feb-14 05:28PM  Drug Stocks Rally: Consider These Profitable Stocks As Pharmaceutical Deals Rise at TheStreet
20-Feb-14 04:30PM  John A. Moran Eye Centers Voyant Biotherapeutics, LLC Enters Into Exclusive R&D Collaboration Agreement with Allergan, Inc. Business Wire
19-Feb-14 12:28AM  Stocks Continue Their Rebound As Uncertainties Subside at Seeking Alpha
14-Feb-14 09:06AM  Scrutiny Over Medical Device Safety Offers Opportunity For VeriTeQ at Seeking Alpha
13-Feb-14 01:51PM  Allergan seeks notification of any Restasis generic filing, says Wells Fargo at theflyonthewall.com
12-Feb-14 03:45PM  Update on Bayer's Aleve Zacks
08:11AM  Allergan outlook has improved, says Wells Fargo at theflyonthewall.com
07-Feb-14 07:06PM  3 Stocks Poised to Dominate the Market in 2014 at Motley Fool
11:30AM  Earnings Miss at AstraZeneca, Outlook Disappoints Zacks
06-Feb-14 05:21PM  Jazz, Valeant Pace Highly Rated Ethical Drugs Group at Investor's Business Daily
09:40AM  Glaxo Beats Q4 Earnings, Shares Up Zacks
05-Feb-14 04:30PM  Allergan Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
11:53AM  Allergan says decision on moving DARPin to phase 3 will be made on phase 2 data theflyonthewall.com
11:22AM  Valeant's Inorganic Growth Could Threaten These 3 Companies in 2014 at Motley Fool
10:24AM  Allergan Beats on Earnings by a Penny Zacks
09:47AM  [$$] Allergan's Revenue Rises at The Wall Street Journal
09:31AM  ALLERGAN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
09:00AM  Allergan Reports Fourth Quarter 2013 Operating Results Business Wire
07:07AM  Q4 2013 Allergan Earnings Release - Before Market Open CCBN
04-Feb-14 03:46PM  Citigroup Jumps on the Allergan Bandwagon at Barrons.com
03:00PM  Positive Trial Data Lifts Pfizer Zacks
07:52AM  Ahead of the Bell: Analyst raises Allergan rating AP
03-Feb-14 12:00PM  Is Allergan (AGN) Poised to Beat Earnings Estimates? Zacks
31-Jan-14 02:30PM  Novo Nordisk Beats on Q4 Earnings Zacks
01:07PM  Roche Misses 2013 Earnings Estimates Zacks
09:07AM  AbbVie Misses on Earnings & Revs, Focus on HCV Data Zacks
30-Jan-14 02:40PM  Eli Lilly Beats on Earnings & Revs, Confirms View Zacks
28-Jan-14 11:04AM  Investors Can't Miss These 3 Pharma Stocks Zacks
27-Jan-14 10:50AM  CHMP Negative on Novartis' RLX030 Zacks
10:50AM  CHMP Negative on Novartis' RLX030
24-Jan-14 11:27AM  Commit To Purchase Allergan At $97.50, Earn 5.2% Annualized Using Options at TheStreet
11:27AM  Commit To Purchase Allergan At $97.50, Earn 5.2% Annualized Using Options
23-Jan-14 12:50PM  Allergan Slips on Restasis Challenge Zacks
12:50PM  Allergan Slips on Restasis Challenge
22-Jan-14 10:40AM  Setback for Roche Zacks
09:54AM  Allergan drops after Watson files for generic Restasis at theflyonthewall.com
09:54AM  Allergan drops after Watson files for generic Restasis
09:00AM  ALLERGAN INC Files SEC form 8-K, Other Events EDGAR Online
09:00AM  ALLERGAN INC Files SEC form 8-K, Other Events
21-Jan-14 04:46PM  ALLERGAN INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:46PM  ALLERGAN INC Files SEC form 8-K, Change in Directors or Principal Officers
15-Jan-14 05:07PM  Allergan Wont Seek Further Foothold in Ireland, CEO Pyott Says at Bloomberg
05:07PM  Allergan Wont Seek Further Foothold in Ireland, CEO Pyott Says
04:50PM  Fish & Richardson Wins Patent Infringement Suit for Allergan Over Generic LUMIGANĀ® 0.01% PR Newswire
04:50PM  Fish & Richardson Wins Patent Infringement Suit for Allergan Over Generic LUMIGANĀ® 0.01%
09:23AM  3 Key Stocks To Watch Today: Illumina, Inc., Allergan, Inc., and Teva Pharmaceutical at Motley Fool
09:23AM  3 Key Stocks To Watch Today: Illumina, Inc., Allergan, Inc., and Teva Pharmaceutical
07:49AM  Early movers: BAC, GM, CMCSA, AAPL, AET & more at CNBC
07:49AM  Early movers: BAC, GM, CMCSA, AAPL, AET & more
06:33AM  Cramer's Mad Money - The Best Mad Money Pick Ever (1/14/14) at Seeking Alpha
06:33AM  Cramer's Mad Money - The Best Mad Money Pick Ever (1/14/14)
12:00AM  IBM, Allergan, Matryoshka, Frack: Intellectual Property at Bloomberg
12:00AM  IBM, Allergan, Matryoshka, Frack: Intellectual Property
14-Jan-14 06:46PM  Court upholds Allergan Lumigan patents, shares rise 6 percent Reuters +5.95%
06:46PM  Court upholds Allergan Lumigan patents, shares rise 6 percent
06:03PM  New Patents Could Sustain Allergan Restasis Franchise Until 2024 at Seeking Alpha
06:03PM  New Patents Could Sustain Allergan Restasis Franchise Until 2024
05:25PM  Stocks Jump But Watch Out for the Disappearing Equity Risk Premium at Barrons.com
05:25PM  Stocks Jump But Watch Out for the Disappearing Equity Risk Premium
01:35PM  Stocks Add To Gains; Allergan Jumps On Ruling at Investor's Business Daily
Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
INGRAM DOUGLAS SPresidentFeb 21Sale125.701961,044Feb 25 05:49 PM
LAVIGNE LOUIS J JRDirectorFeb 21Sale125.795,400679,2440Feb 24 07:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Option Exercise58.5523,0001,346,65029,401Feb 21 04:56 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Option Exercise40.1638,9001,562,22455,491Feb 21 04:59 PM
HUDSON DAWN EDirectorFeb 19Sale126.354,200530,68311,600Feb 21 05:14 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Sale126.3938,9004,916,49316,591Feb 21 04:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Sale126.6623,0002,913,1116,401Feb 21 04:56 PM
Sherman Scott DExecutive Vice President, HRFeb 18Option Exercise75.585,000377,90013,220Feb 19 02:44 PM
Sherman Scott DExecutive Vice President, HRFeb 18Sale125.745,000628,7008,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Option Exercise55.9884,0004,701,90085,058Feb 19 02:41 PM
Sherman Scott DExecutive Vice President, HRFeb 14Sale124.761708,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Sale124.4084,00010,449,4321,058Feb 19 02:41 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Option Exercise36.15252,0009,109,800417,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Option Exercise65.9223,8751,573,76930,754Feb 13 05:54 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Sale123.12252,00031,025,560165,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Sale123.5223,8752,949,0416,879Feb 13 05:54 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Option Exercise55.9817,000951,57523,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Option Exercise55.2054,6003,014,01924,123Feb 13 05:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Sale121.8217,0002,070,9576,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Sale122.3954,6006,682,69612,723Feb 13 05:59 PM
Sherman Scott DExecutive Vice President, HRFeb 10Option Exercise75.585,000377,90013,325Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 10Sale120.005,000600,0008,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Option Exercise64.47105,5006,801,585122,371Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Option Exercise73.044,500328,68012,825Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 07Sale118.554,500533,4848,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Sale117.74105,50012,421,04316,871Feb 11 08:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Option Exercise55.9842,0002,350,95059,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Sale117.8042,0004,947,60017,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Option Exercise55.9842,0002,350,95059,327Jan 10 06:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Sale113.8042,0004,779,60017,327Jan 10 06:37 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Option Exercise53.7152,5002,819,77545,547Dec 30 05:18 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Sale110.0552,5005,777,5508,047Dec 30 05:18 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise36.1533,0001,192,95033,827Dec 20 07:41 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise0.0033,000033,827Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Dec 20 07:41 PM
HUDSON DAWN EDirectorNov 27Sale97.463,000292,38215,800Dec 02 04:52 PM
Jones Trevor MDirectorOct 15Option Exercise51.721,00051,7159,142Oct 16 04:54 PM
Jones Trevor MDirectorOct 15Sale90.142,000180,2807,142Oct 16 04:54 PM
Jones Trevor MDirectorSep 16Option Exercise51.721,00051,71510,142Sep 17 07:38 PM
Jones Trevor MDirectorSep 16Sale89.782,000179,5608,142Sep 17 07:38 PM
Jones Trevor MDirectorAug 15Option Exercise51.721,00051,71511,142Aug 16 07:38 PM
Jones Trevor MDirectorAug 15Sale89.892,000179,7809,142Aug 16 07:38 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOAug 06Option Exercise47.9269,2003,316,06056,871Aug 08 05:01 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOAug 06Sale91.1769,2006,308,74616,871Aug 08 05:01 PM
Jones Trevor MDirectorJul 15Option Exercise51.721,00051,71512,142Jul 17 06:17 PM
Jones Trevor MDirectorJul 15Sale91.152,000182,30010,142Jul 17 06:17 PM
Jones Trevor MDirectorJun 17Option Exercise36.491,00036,49013,142Jun 18 07:58 PM
Jones Trevor MDirectorJun 17Sale101.252,000202,50011,142Jun 18 07:58 PM
Jones Trevor MDirectorMay 15Option Exercise36.491,00036,49014,142May 17 03:48 PM
Jones Trevor MDirectorMay 15Sale103.402,000206,80012,142May 17 03:48 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOMay 09Option Exercise58.5540,1002,347,85556,971May 10 08:54 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOMay 09Sale103.7240,1004,159,28016,871May 10 08:54 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOMay 08Option Exercise57.1443,9002,508,54560,771May 10 08:54 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOMay 08Sale103.2943,9004,534,22916,871May 10 08:54 PM